View in EDS

The social value of lecanemab for patients with early Alzheimer's disease in Japan.

Saved in:

Bibliographic Details
Title:	The social value of lecanemab for patients with early Alzheimer's disease in Japan.
Authors:	Igarashi A; Department of Health Policy and Public Health, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan., Azuma-Kasai M; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Tani M; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Utsumi T; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Shibahara H; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan., Inoue S; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan., Rothwell S; Eisai Europe Ltd., Hatfield, UK., Kamanaka G; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Sakata Y; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Hiyoshi H; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Tomita K; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.
Source:	Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2026 Jul; Vol. 112 (1), pp. 283-301. Date of Electronic Publication: 2026 May 10.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: SAGE Publications Country of Publication: United States NLM ID: 9814863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1875-8908
DOI:	10.1177/13872877261447312